Pharmaceuticals(42)

  • Novel Method for Diagnosing and Treating Relapsed Obesity (No. T4-1805)

    Obesity is the health epidemic of the modern world, with nearly half the global adult population being categorized as obese. ... Read more
    Associate Professor Eran Elinav

    Eran Elinav

    Faculty of Biology

    5659
  • A Novel Method of Preventing or Treating Secondary Infections by Inhibition of Membrane Type I Matrix-Metalloproteinase-1 (No. T4-1790)

    A novel method of preventing secondary infections, by inhibition of membrane type I matrix-metalloproteinase-1 (MT1-MMP), which reduces degradation of the extra-cellular matrix. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    5647
  • A Novel Method for Treating Drug-Resistant Lung Cancer Using a Combination of Antibodies (No. T4-1774)

    A novel method for treating tyrosine kinase inhibitor (TKI)-resistant cancer, by using a combination of three different antibodies. ... Read more
    Extension Service Yosef Yarden

    Yosef Yarden

    Faculty of Biology

    5635
  • ERBB2 as a Novel Target to Treat Heart Failure by Inducing Cardiomyocyte Proliferation (No. T4-1752)

    Existing treatments fail to compensate the irreversible loss of functional cardiomyocytes (CM), thus presenting a major medical unmet need. ... Read more
    Full Professor Eldad Tzahor

    Eldad Tzahor

    Faculty of Biology

    5623
  • rPTE with Potent Organophosphate (OPH) Activities (No. T4-1750)

    Organophosphates are toxic compounds found in chemical warfare agents, such as nerve gases, and insect pesticides.Use of volatile nerve gas agents by terrorist organizations is a key concern of governments around the world. V-type nerve agents (e.g. ... Read more
    Full Professor Dan S. Tawfik

    Dan S. Tawfik

    Biochemistry

    5620
  • A Novel Approach for Treating Cancer and Collagen-Associated Diseases by Using Anti-LOXL-2 Antibody (No. T4-1743)

    Disruption to the Extra-Cellular Matrix (ECM) is associated with many pathological conditions, such as various cancer types and tissue fibrosis, and also correlates with high tumor malignancy. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    5611
  • P38 and JNK Inhibitor as Potential Treatment for Various Pathologies (No. T4-1733)

    The development of kinase inhibitors to treat inflammatory diseases was proved beneficial, however, designing specific inhibitors with minimal side effects and prolonged efficacy is challenging as drug resistance often develops. ... Read more
    Full Professor Rony Seger

    Rony Seger

    Faculty of Biology

    5605
  • Long Chain Sphingoid as Preventing Infection (No. T4-1673)

    CF is the most common autosomal recessive disorder in western countries, affecting approximately 30,000 people in the US alone. A major risk in CF arises from chronic bacterial lung infections, affecting 80% of CF patients by the age of 25. ... Read more
    Full Professor Anthony H. Futerman

    Anthony H. Futerman

    Faculty of Biochemistry

    5584
  • MRI of Tissue Fibrosis Without Contrast Agent (No. T4-1665)

    Improved magnetic resonance imaging (MRI) for cardiac fibrosis and other fibrotic diseases.Myocardial fibrosis is associated with worsening ventricular systolic function, abnormal cardiac remodeling, and increased ventricular stiffness, significantly increasing the risk of adverse cardiac outcome ... Read more
    Full Professor Michal Neeman

    Michal Neeman

    Faculty of Biology

    5575
  • Affinity Maturated T-Cell Receptor (No. T4-1662)

    Immunotherapy, that is the use of the immune system to treat cancer, is currently a leading candidate in the combat against cancer. ... Read more
    Emeritus Rachel Lea Eisenbach

    Rachel Lea Eisenbach

    Faculty of Biology

    5572

Pages

Subscribe to Pharmaceuticals